
Escalante provides a platform for scalable, functional single-molecule proteomics to help predict how cells respond to therapeutic perturbations. The company combines molecular biology, protein biochemistry, and artificial intelligence to enable AI-driven models that interpret proteomic data at the single-molecule level. This is a biotech platform aimed at researchers and drug developers, integrating core proteomics technology with machine learning pipelines. The focus is on enabling transformative insights for biology and drug discovery, scaling research workflows and datasets. In practice, Escalante targets laboratory scientists and R&D teams in biotech and pharmaceutical settings seeking advanced proteomics insights.

Escalante provides a platform for scalable, functional single-molecule proteomics to help predict how cells respond to therapeutic perturbations. The company combines molecular biology, protein biochemistry, and artificial intelligence to enable AI-driven models that interpret proteomic data at the single-molecule level. This is a biotech platform aimed at researchers and drug developers, integrating core proteomics technology with machine learning pipelines. The focus is on enabling transformative insights for biology and drug discovery, scaling research workflows and datasets. In practice, Escalante targets laboratory scientists and R&D teams in biotech and pharmaceutical settings seeking advanced proteomics insights.